切换至 "中华医学电子期刊资源库"

中华肺部疾病杂志(电子版) ›› 2023, Vol. 16 ›› Issue (02) : 285 -289. doi: 10.3877/cma.j.issn.1674-6902.2023.02.038

综述

老年慢性阻塞性肺疾病诊断与治疗新进展
张灵1,(), 杨荀1, 蒋水平1, 李小华1   
  1. 1. 610041 成都,四川大学华西医院呼吸与危重症医学科
  • 收稿日期:2022-12-13 出版日期:2023-04-25
  • 通信作者: 张灵
  • 基金资助:
    四川省科技计划项目(2019YFS0339)

New progress in clinical diagnosis and treatment of chronic obstructive pulmonary disease in the elderly

Ling Zhang1(), Xun Yang1, Shuiping Jiang1   

  • Received:2022-12-13 Published:2023-04-25
  • Corresponding author: Ling Zhang
引用本文:

张灵, 杨荀, 蒋水平, 李小华. 老年慢性阻塞性肺疾病诊断与治疗新进展[J]. 中华肺部疾病杂志(电子版), 2023, 16(02): 285-289.

Ling Zhang, Xun Yang, Shuiping Jiang. New progress in clinical diagnosis and treatment of chronic obstructive pulmonary disease in the elderly[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2023, 16(02): 285-289.

慢性阻塞性肺疾病(chronic obstructive pulmonary disease, COPD)主要疾病特征为持续存在的呼吸系统症状与气流受限,是老年多发性呼吸系统疾病,且近些年由于社会老年化程度的不断加深,COPD的发生率也在不断攀升。2020年COPD的致死率位居全球死亡原因的第3位[1,2]。我国流行病学研究显示≥40岁人群中COPD的发生率高达13.7%[3]。国外一项针对人体肺健康和COPD的队列研究显示,相较早期未得到诊断的轻中度COPD患者,得到早期诊断、早期干预的COPD患者可能表现出肺组织功能逆转现象[4]。随着医学技术的进步与研究的不断深入,针对COPD的诊断方法不断增加,相应的治疗手段也不断丰富,为老年COPD患者得到早期诊断、获得良好预后奠定了良好基础。本文就近几年关于老年COPD的诊断与治疗相关方法进行总结分析论述,通过整理论述为往后老年COPD诊断及治疗方法的选择提供一定参考。

7
魏 霞,于 楠,米九运,等. 轻度二氧化碳潴留慢性阻塞性肺疾病肺功能和CT的特征[J/CD]. 中华肺部疾病杂志(电子版), 2020, 13(1): 23-27.
8
Britze J, Frederiksen JL. Optical coherence tomography in multiple sclerosis[J]. Eye (Lond), 2018, 32(5): 884-888.
9
Ding M, Chen Yu, Guan WJ, et al. Measuring airway remodeling in patients with different COPD staging using endobronchial optical coherence tomography[J]. Chest, 2016, 150(6): 1281-1290.
10
Xiao J, Li QD. Multi-slice spiral CT evaluation of chronic radiation colitis and rectitis[J]. Exp Ther Med, 2020, 20(4): 3033-3040.
11
Tanabe N, Vasilescu DM, McDonough JE, et al. Micro-computed tomography comparison of preterminal bronchioles in centrilobular and panlobular emphysema[J]. Am J Respir Crit Care Med, 2017, 195(5): 630-638.
12
Kellenberger CJ, Amaxopoulou C, Moehrlen U, et al. Structural and perfusion magnetic resonance imaging of congenital lung malformations[J]. Pediatr Radiol, 2020, 50(8): 1083-1094.
13
Ter-Karapetyan A, Triphan SMF, Jobst BJ, et al. Towards quantitative perfusion MRI of the lung in COPD: The problem of short-term repeatability[J]. PLoS One, 2018, 13(12): e0208587.
14
段利科,张周龙. MRI与超声心动图对COPD患者右室功能变化的评估价值[J]. 中国CT和MRI杂志2018, 16(11): 72-74, 103.
15
Saleem A, Sharif S, Jarvis S, et al. A comprehensive review on vitamin D as a novel therapeutic agent in chronic obstructive pulmonary disease[J]. Cureus, 2021, 13(2): e13095.
16
Uluçoban H, Dirol H, Özdemir T. The effect of vitamin D deficiency in chronic obstructive pulmonary disease[J]. Turk Thorac J, 2021, 22(3): 242-246.
17
MacLeod M, Papi A, Contoli M, et al. Chronic obstructive pulmonary disease exacerbation fundamentals: Diagnosis, treatment, prevention and disease impact[J]. Respirology, 2021, 26(6): 532-551.
18
Tsubakihara Y, Moustakas A. Epithelial-mesenchymal transition and metastasis under the control of transforming growth factor β[J]. Int J Mol Sci, 2018, 19(11): 3672.
19
熊 福,戴晓天,罗光明. 稳定期COPD患者血清镁、钙和维生素D水平与生活质量评分的相关性研究[J]. 浙江医学2017, 39(17): 1445-1448.
20
张盛斌,郑吼真,张淇钏,等. 血清25-羟维生素D水平与COPD急性加重期患者免疫炎症指标、CAT评分的相关性研究[J]. 广东药科大学学报2020, 36(5): 719-723.
21
Xie F, Ling L, van Dam H, et al. TGF-β signaling in cancer metastasis[J]. Acta Biochim Biophys Sin (Shanghai), 2018, 50(1): 121-132.
22
杨剑秋,毕建洲. 红细胞分布宽度对肺部感染所致脓毒症预后的评估价值分析[J]. 中华全科医学2020, 18(11): 1827-1829, 1915.
23
Hu GP, Zhou YM, Wu ZL, et al. Red blood cell distribution width is an independent predictor of mortality for an acute exacerbation of COPD[J]. Int J Tuberc Lung Dis, 2019, 23(7): 817-823.
24
边 娟,李水霞,白雪瑞,等. 红细胞分布宽度水平在预测慢性阻塞性肺疾病急性加重的应用价值研究[J]. 中国医药科学2022, 12(12): 147-150.
25
Kalemci S, Akin F, Sarihan A, et al. The relationship between hematological parameters and the severity level of chronic obstructive lung disease[J]. Pol Arch Intern Med, 2018, 128(3): 171-177.
26
刘元明,文 璐,肖三玲,等.慢性阻塞性肺疾病急性加重患者外周血中性粒细胞/淋巴细胞比值、红细胞分布宽度的诊断价值及相关性分析[J]. 中国呼吸与危重监护杂志2021, 20(12): 842-845.
27
王美华,陈丽琴. 慢性阻塞性肺疾病急性加重期患者血清microRNA-146a水平及其临床意义[J]. 中国现代医学杂志2020, 30(18): 36-40.
28
Liu X, Qu J, Xue W, et al. Bioinformatics-based identification of potential microRNA biomarkers in frequent and non-frequent exacerbators of COPD[J]. Int J Chron Obstruct Pulmon Dis, 2018, 16(13): 1217-1228.
29
Osei ET, Florez-Sampedro L, Tasena H, et al. miR-146a-5p plays an essential role in the aberrant epithelial-fibroblast cross-talk in COPD[J]. Eur Respir J, 2017, 49(5): 1602538.
30
O′Sullivan MJ, Jang JH, Panariti A, et al. Airway epithelial cells drive airway smooth muscle cell phenotype switching to the proliferative and pro-inflammatory phenotype[J]. Front Physiol, 2021, 6(12): 687654.
31
高健敏,朱勇德,符国平. 血浆miRNA-145、miRNA-183水平在慢性阻塞性肺疾病急性加重期诊断及预后评估中的应用[J]. 郑州大学学报(医学版), 2022, 57(4): 491-495.
32
谢羽飞,赵 洁,杨益秀,等. miR-186在慢性阻塞性肺疾病患者血清外泌体中表达与临床意义[J]. 海南医学院学报2020, 26(24): 1855-1858, 1864.
33
Lacedonia D, Palladino GP, Foschino-Barbaro MP, et al. Expression profiling of miRNA-145 and miRNA-338 in serum and sputum of patients with COPD, asthma, and asthma-COPD overlap syndrome phenotype[J]. Int J Chron Obstruct Pulmon Dis, 2017, 23(12): 1811-1817.
34
付延鑫,戴 昂,董 亮,等. 祛痰/抗氧化药物治疗COPD疗效与安全性的网状Meta分析[J]. 中国药房2021, 32(22): 2778-2784.
35
Dal Negro RW, Wedzicha JA, RESTORE group, et al. Effect of erdosteine on the rate and duration of COPD exacerbations: the RESTORE study[J]. Eur Respir J, 2017, 50(4): 1700711.
36
Calverley PM, Page C, Dal Negro RW, et al. Effect of erdosteine on COPD exacerbations in COPD patients with moderate airflow limitation[J]. Int J Chron Obstruct Pulmon Dis, 2019, 2(14): 2733-2744.
37
Ahmad AM, Mohammed HA, Faris TM, et al. Nano-structured lipid carrier-based oral glutathione formulation mediates renoprotection against cyclophosphamide-induced nephrotoxicity, and improves oral bioavailability of glutathione confirmed through RP-HPLC micellar liquid chromatography[J]. Molecules, 2021, 26(24): 7491.
38
胡小燕,郑 晓,嵇华夏,等. N-乙酰半胱氨酸联合理疗对慢性阻塞性肺疾病患者白细胞介素-6和呼吸功能的影响[J]. 中国药物与临床2021, 21(5): 4.
39
Cazzola M, Calzetta L, Facciolo F, et al. Pharmacological investigation on the anti-oxidant and anti-inflammatory activity of N-acetylcysteine in an ex vivo model of COPD exacerbation[J]. Respir Res, 2017, 18(1): 26.
1
Balkissoon R. Journal Club-COPD2020 Update. Global initiative for chronic obstructive lung disease 2020 report and the journal of the COPD foundation special edition, moving to a new definition for COPD: " COPD Gene? 2019" [J]. Chronic Obstr Pulm Dis, 2019, 6(4): 64-72.
2
任成山,王关嵩,钱桂生. 慢性阻塞性肺疾病的成因及其治疗的困惑与希望[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(2): 127-141.
3
Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health study): a national cross-sectional study[J]. Lancet, 2018, 391(10131): 1706-1717.
4
Aaron SD, Tan WC, Bourbeau J, et al. Diagnostic instability and reversals of chronic obstructive pulmonary disease diagnosis in individuals with mild to moderate airflow obstruction[J]. Am J Respir Crit Care Med, 2017, 196(3): 306-314.
5
Okajima Y, Come CE, Nardelli P, et al. Luminal plugging on chest CT scan: Association with lung function, quality of life, and COPD clinical phenotypes[J]. Chest, 2020, 158(1): 121-130.
6
van Dort MJ, Romme EAPM, Smeenk FWJM, et al. Diagnosis of vertebral deformities on chest CT and DXA compared to routine lateral thoracic spine X-ray[J]. Osteoporos Int, 2018, 29(6): 1285-1293.
40
Janjua S, Fortescue R, Poole P. Phosphodiesterase-4 inhibitors for chronic obstructive pulmonary disease[J]. Cochrane Database Syst Rev, 2020, 5(5): CD002309.
41
Xu M, Li S, Wang J, et al. Cilomilast ameliorates renal tubulointerstitial fibrosis by inhibiting the TGF-β1-Smad2/3 signaling pathway[J]. Front Med (Lausanne), 2021, 21(7): 626140.
42
Li S, Wang G, Wang C, et al. The REACH trial: A randomized controlled trial assessing the safety and effectiveness of the Spiration Valve System in the treatment of severe emphysema[J]. Respiration, 2019, 97(5): 416-427.
43
赵 文,王 鹏. 支气管热蒸汽消融术后COPD缓解期患者的中医辨治思路初探[J]. 四川中医2020, 38(9): 35-37.
44
Hummel JP, Mayse ML, Dimmer S, et al. Physiologic and histopathologic effects of targeted lung denervation in an animal model[J]. J Appl Physiol (1985), 2019, 126(1): 67-76.
45
Srikanthan K, Kistemaker L, Slebos DJ, et al. Targeted lung denervation modulates the bronchial epithelial transcriptome in COPD[J]. Eur Respir J, 2019, 54 (63): OA5169.
46
Moore RF, Lile DJ, Abbas AE. Current status of spray cryotherapy for airway disease[J]. J Thorac Dis, 2017, 9(Suppl 2): S122-S129.
47
Slebos DJ, Breen D, Coad J, et al. Safety and histological effect of liquid nitrogen metered spray cryotherapy in the lung[J]. Am J Respir Crit Care Med, 2017, 196(10): 1351-1352.
48
Valipour A, Fernandez-Bussy S, Ing AJ, et al. Bronchial rheoplasty for treatment of chronic bronchitis. Twelve-month results from a multicenter clinical trial[J]. Am J Respir Crit Care Med, 2020, 202(5): 681-689.
49
张继华,张丽琼,杨耀鹏,等. 营养和心理干预联合肺康复训练操对慢阻肺患者的疗效[J]. 中华医学杂志2020, 100(2): 110-115.
50
谢林艳,殷稚飞,宋丽丽,等. 五禽戏对稳定期慢性阻塞性肺疾病的肺康复疗效及应用[J]. 中国康复2021, 36(2): 117-120.
51
冯晓丽,姜 轶,巫道琳,等. 缩唇腹式呼吸联合阻力呼吸训练器对老年慢性阻塞性肺病稳定期患者康复效果和生活质量的影响[J]. 实用医院临床杂志2018, 15(2): 121-124.
52
Nolan CM, Rochester CL. Exercise training modalities for people with chronic obstructive pulmonary disease[J]. COPD, 2019, 16(5-6): 378-389.
53
毛国艳. 上肢康复锻炼结合呼吸训练对老年COPD患者生活质量的影响[J]. 国际护理学杂志2017, 36(8): 1047-1050.
54
Chen Y, Niu M, Zhang X, et al. Effects of home-based lower limb resistance training on muscle strength and functional status in stable chronic obstructive pulmonary disease patients[J]. J Clin Nurs, 2018, 27(5-6): e1022-e1037.
55
郑湘毅,李秀萍,陈炳锋,等. 不同运动频次高强度下肢踏车锻炼对中重度COPD病人肺康复的疗效观察[J]. 实用老年医学2020, 34(5): 443-446.
56
覃福佳,崔妙玲,农 荧,等. 踏车运动对慢性阻塞性肺疾病患者康复效果的Meta分析[J]. 中国老年学杂志2021, 41(5): 997-1002.
[1] 史学兵, 谢迎东, 谢霓, 徐超丽, 杨斌, 孙帼. 声辐射力弹性成像对不可切除肝细胞癌门静脉癌栓患者放射治疗效果的评价[J]. 中华医学超声杂志(电子版), 2024, 21(08): 778-784.
[2] 仲卫冬, 胡根, 邵国益. 腹腔开放合并肠空气瘘的管理[J]. 中华损伤与修复杂志(电子版), 2024, 19(05): 462-462.
[3] 张静, 刘畅, 华成舸. 妊娠期患者口腔诊疗进展[J]. 中华口腔医学研究杂志(电子版), 2024, 18(05): 340-344.
[4] 梁孟杰, 朱欢欢, 王行舟, 江航, 艾世超, 孙锋, 宋鹏, 王萌, 刘颂, 夏雪峰, 杜峻峰, 傅双, 陆晓峰, 沈晓菲, 管文贤. 联合免疫治疗的胃癌转化治疗患者预后及术后并发症分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 619-623.
[5] 许月芳, 刘旺, 曾妙甜, 郭宇姝. 多粘菌素B和多粘菌素E治疗外科多重耐药菌感染临床疗效及安全性分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 700-703.
[6] 王宇, 徐芳泉, 周旋, 姚晓峰, 李强. 不断提高分化型甲状腺癌根治性切除规范化[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 473-476.
[7] 孙辉, 李长霖. 分化型甲状腺癌根治性切除术中的关键考量与策略[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 477-481.
[8] 张腾花, 尚培中, 王晓梅, 李晓武, 王金, 苗建军, 刘冰. 外伤性脾破裂三阶梯分层治疗策略[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 510-512.
[9] 高建新, 王啸飞, 于淼, 路夷平. 局部进展期直肠癌新辅助治疗后行ISR术远切缘距离的临床研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 539-543.
[10] 李阳, 董峰, 曾立鹏. 局部进展期直肠癌新辅助治疗后腹腔镜TaTME与TME中的对比研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 547-550.
[11] 吴伟宙, 王琼仁, 詹雄宇, 郑明星, 李亚县. 广东省医学会泌尿外科疑难病例多学科会诊(第16期)——左肾肉瘤样癌[J]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(05): 525-529.
[12] 周锐, 罗飞. 骨质疏松椎体骨折的分型进展[J]. 中华老年骨科与康复电子杂志, 2024, 10(05): 315-320.
[13] 梁艳娉, 陈燕柔, 梁运啸, 白飞虎, 吴斌, 王省. 华南地区门静脉高压食管胃静脉曲张出血内镜治疗现状调研分析[J]. 中华消化病与影像杂志(电子版), 2024, 14(05): 390-395.
[14] 张平骥, 徐钰, 李天水, 庞文翼, 符师宁, 张梦圆. 重症患者镇静治疗现状及期望的调查研究[J]. 中华临床医师杂志(电子版), 2024, 18(06): 562-567.
[15] 王昌前, 林婷婷, 宁雨露, 王颖杰, 谭文勇. 光免疫治疗在肿瘤领域的临床应用新进展[J]. 中华临床医师杂志(电子版), 2024, 18(06): 575-583.
阅读次数
全文


摘要